Akebia Therapeutics, Inc. (AKBA) [Rocket]

In millions, except per share items	Jun-30-23	Mar-31-23	Dec-31-22	Jun-30-22	Mar-31-22	Dec-31-21	Sep-30-21	Jun-30-21
	8-K	10-Q	8-K	10-Q	10-Q	10-K	10-Q	10-Q
Assets
Cash and equivalents		57.0	90.5	143.9	174.6	149.8	207.2	247.0
Accounts receivable, net		17.8	39.2	81.9	64.6	50.9	49.7	35.0
Inventories		20.6	21.8	36.3	39.4	38.2	33.7	37.9
Other current assets		25.4	33.5	42.1	24.1	33.1	39.5	11.2
Total current assets		120.7	184.9	304.2	302.7	272.0	330.1	331.1
Property, plant, and equipment, net		4.8	5.2	6.0	6.5	6.8	7.2	7.7
Goodwill		55.1	55.1	55.1	55.1	55.1	55.1	55.1
Other fixed assets		5.2	5.4	35.0	39.4	49.8	69.6	67.5
Total assets		276.9	351.8	521.8	535.4	525.6	602.3	611.9

Accounts payable		12.6	18.0	24.9	19.5	33.6	28.8	42.0
Accrued expenses		46.4	71.0	91.3	109.7	104.5	144.7	111.7
Current portion of long-term debt	0.0	24.0	32.0	98.2	97.8	97.5	0.0	0.0
Current portion of long-term debt		24.0	32.0	98.2	97.8	97.5
Deferred revenues			3.7	5.0	10.4		15.7	11.9
Other current liabilities				14.2	16.5	20.9
Total current liabilities	0.0	82.9	124.8	233.7	253.9	256.5	189.2	165.6
Long-term debt		26.3	34.1				97.2	96.9
Other liabilities		182.0	183.7	225.8	255.3	192.6	178.7	174.7
Total liabilities	0.0	291.2	342.5	459.5	509.2	449.1	465.1	437.2

Shareholders' equity [+]		-14.4	9.3	62.3	26.1	76.5	137.2	174.6
Paid-in capital		1,564.8	1,562.2	1,555.8	1,548.9	1,536.8	1,526.8	1,504.8
Retained earnings		-1,579.1	-1,552.9	-1,493.5	-1,522.8	-1,460.4	-1,389.7	-1,330.1
Tangible shareholders' equity		-69.4	-45.7	7.2	-28.9	21.4	82.1	119.6